Clinical trial
Granulocyte-Colony Stimulating Factor Adjunct Therapy for Biliary Atresia
NCT03395028 is registered in ClinicalTrials.gov with Holterman, Ai-Xuan, M.D. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Granulocyte-Colony Stimulating Factor Adjunct Therapy for Biliary Atresia
- Lead sponsor
- Holterman, Ai-Xuan, M.D.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 15, 2018
- Completion date
- January 31, 2020
- Enrollment
- 6 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.